Elsubrutinib,Upadacitinib,ABBV-599
AbbVie
['upadacitinib', 'elsubrutinib', 'abbv-599', ' upa ']
#eular2023 #pos1133 consistent with clinical response in phase 2 rct, therapy with updacitinib alone and abv599-hd (elsubrutinib + upadacitinib) modulated ifn-i signalling pathways (ifn gene expression &amp; proteomics). assuring therapeutic evidence 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏